Solid Biosciences Inc. (SLDB) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 46 days, typically, give or take 33 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q4 FY2025Fri, Mar 6, 2026after close 65 8-K
Q3 FY2025Mon, Nov 3, 2025after close 34 8-K
Q4 FY2024Tue, Feb 18, 2025before open 49 8-K
Q3 FY2023Mon, Jan 8, 2024before open 100 8-K
Q3 FY2022Mon, Jan 9, 2023before open 101 8-K
Q2 FY2022Thu, Aug 11, 2022before open 42 8-K
Q1 FY2022Wed, Apr 27, 2022before open 27 8-K
Q4 FY2021Mon, Jan 10, 2022before open 10 8-K

What they guided beta

Q3 FY2025 "Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions - Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to have dosed 30 participants in total by early 2026, then plans to meet with the FDA to discuss potential registrational pathways in H1 2026 - - SGT-003 has been generally well tolerated using a steroid-only prophylactic immunomodulation regimen; cardiac safety monitoring continued to show reduction in cardiac i" exhibit
Q3 FY2025 "Later in the fourth quarter of 2025, we also expect to activate our first clinical trial site for ARTEMIS, a first-in-human Phase 1b clinical trial evaluating SGT-501, our gene therapy candidate intended to treat catecholaminergic polymorphic ventricular tachycardia." exhibit
Q3 FY2025 "The Company expects to dose a total of 30 participants by early 2026." exhibit
Q3 FY2025 "Critically, Solid has aligned with the FDA on SGT-003’s potency assay strategy and will continue additional commercial-readiness CMC activities, with PPQ manufacturing batches expected to be completed in 2026." exhibit
Q3 FY2025 "SGT-501 for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) In the fourth quarter of 2025, Solid expects to activate the first clinical trial site for ARTEMIS, a first-in-human, open-label, Phase 1b clinical trial of SGT-501." exhibit
Q4 FY2024 ">10 participants total projected to be 50 1 N=3, MEAN 110% : dosed by early Q2 2025 0 Participant Participant Participant Mean 1 2 3" exhibit
Q4 FY2024 "Approximately 20 participants total projected to be dosed by Q4 2025 Baseline Day 90 Day 90 DYSTROPHIN POSITIVE In first 3 participants dosed (Day 90), FIBERS (IF) SGT-003 showed: 1 N=3, MEAN 78% :" exhibit
Q4 FY2024 "Adverse Events expected and consistent with AAV gene therapy 18 © 2025 Solid Biosciences" exhibit
Q4 FY2024 "Participant enrollment continues: >10 participants in total expected to be dosed by early Q2 2025" exhibit
Q4 FY2024 "Global clinical site expansion underway: additional sites expected to be activated by year-end 2025" exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/SLDB
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/SLDB

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

SLDB earnings date badge

HTML

<a href="https://veritasdata.dev/company/SLDB/"><img src="https://veritasdata.dev/embed/SLDB.svg" alt="SLDB earnings date" width="240" height="56"></a>

Markdown

[![SLDB earnings date](https://veritasdata.dev/embed/SLDB.svg)](https://veritasdata.dev/company/SLDB/)

Script

<script async src="https://veritasdata.dev/embed/SLDB.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/SLDB"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.